Long-Acting HIV Prevention: Injectable Treatment Approved in France
Paris – A new era in HIV prevention is dawning in France with the arrival of cabotegravir, an injectable long-acting preventative treatment. Approved via a government decree on February 26, 2026, this medication offers a significant advancement over existing daily oral PrEP (pre-exposure prophylaxis) options, particularly for individuals who struggle with adherence to a pill-based … Read more